. Effect of locally applied drugs on the pH of luminal fluid in the endolymphatic sac of guinea pig. Am J Physiol Regulatory Integrative Comp Physiol 279: R1695-R1700, 2000.-The aim of the present work was to assess the effect of various drugs applied locally on the pH of the luminal fluid (pH lum ) in guinea pig endolymphatic sac. pH lum and transepithelial potential, when measured in vivo by means of double-barrelled pHsensitive microelectrodes, were 7.06 Ϯ 0.08 and ϩ6.1 Ϯ 0.34 mV (mean Ϯ SE; n ϭ 84), respectively, which is consistent with a net acid secretion in the luminal fluid of the endolymphatic sac. Bafilomycin and acetazolamide increased and decreased, respectively, pH lum . Amiloride, ethylisopropylamiloride, ouabain, and Schering 28080 had no effect on pH lum . Results obtained with inhibitors of anionic transport systems were inconclusive; e.g., DIDS reduced pH lum , whereas neither SITS nor triflocin had any effect. We conclude that bafilomycin-sensitive H ϩ -ATPase activity accounts for the transepithelial acid gradient measured in the endolymphatic sac and that intracellular and membranebound carbonic anhydrase probably participates in regulating endolymphatic sac pH lum . The relationship between acid pH, endolymph volume, and Ménière's disease remains to be further investigated.
acid-base; endolymph; inner ear; H ϩ -ATPase; Ménière's disease THE ENDOLYMPHATIC SAC is a monolayer epithelium in the inner ear located partly within the temporal bone and partly within the dura mater of the posterior cerebral fossa. Its luminal fluid is contiguous with cochleovestibular endolymph. Cochleovestibular endolymph is a Krich extracellular fluid whose homeostasis of composition and volume is essential to mechanoelectrical transduction, i.e., the first step in auditory and vestibular sensorineural input. Its basolateral compartment is composed of a loose connective tissue that communicates with the cochleovestibular perilymphatic space.
The endolymphatic sac is involved in the regulation of the volume of endolymph by two different mechanisms. The first is endolymph resorption, which has been demonstrated by the endolymphatic hydrops, i.e., the increase in cochleovestibular endolymph volume observed after the experimental destruction of the endolymphatic sac (14) . Theoretically, endolymph resorption by the endolymphatic sac should take place in the basal state to compensate the constant secretion of water into the endolymph induced by the hyperosmolality of cochleovestibular endolymph (23) . However, indirect measurement of the longitudinal flow of endolymph, i.e., the water flow from cochleovestibular endolymph to the endolymphatic sac lumen, showed that this flow did not differ from zero in the basal state, and it increased when cochlear endolymph was transiently increased (20) . The second way by which the endolymphatic sac regulates endolymph volume is by the luminal secretion of osmotically active glycoconjugates. This secretion has been demonstrated in the basal state in most animal species and was stimulated in experimental situations that tend to reduce the volume of endolymph, such as after glycerol administration. In these experimental situations, luminally secreted osmotically active glycoconjugates could retain water in endolymph and thus avoid the collapse of cochleovestibular endolymphatic compartment (27) .
In human pathology, the most common cause of dysregulation of endolymph volume is endolymphatic hydrops. This hydrops is known to constitute the anatomic substratum of Ménière's disease, a syndrome comprising vertigo, hearing loss, and tinnitus, and histologically characterized by an endolymphatic hydrops (11) . Malfunction of the endolymphatic sac has been suggested as part of this pathology as lesions of this structure (agenesis, fibrosis, inflammation) have been observed in some cases (for review, see Ref. 16 ). Determination of the ionic transport systems involved in both resorptive and secretory functions of the sac may help us to better understand the etiopathogenic mechanism of Ménière's disease. It could also facilitate improvements in the medical treatment of this pathology, in particular diuretic treatment that has been widely used on an empirical basis with controversial results (for review, see Ref. 5) . Among the diuretics, two drugs, acetazolamide and amiloride, interacting with acid-base transport systems have been reported to improve the evolution of both Ménière's disease and experimental endolymphatic hydrops (5, 21, 26) . For this reason, we investigated endolymphatic sac acidbase transport systems of the guinea pig endolymphatic sac by in vivo measurements of the evolution of the transepithelial potential (ESP) and luminal pH (pH lum ) of the endolymphatic sac after local administration of inhibitors of acid-base transport systems. The results are consistent with active proton secretion in the lumen by an apical vacuolar type H ϩ -ATPase and with the involvement of carbonic anhydrase in acid-base net transport.
MATERIALS AND METHODS

Animal Preparation and Endolymphatic Sac Approach
Adult male pigmented guinea pigs (300-400 g body wt, Elevage d'Ardenay, France) were fed with a laboratory chow of constant composition (C15-50, Extralabo Pietrement, Provins, France), and free access to tap water was allowed until the beginning of the experiment. The care and use of the animals had been approved by Ministère de l'Agriculture et de la Forêt (approval number 5521).
Anesthesia was obtained with two successive (in 30 min) intramuscular injections of 2 ml/kg body wt of a mixture of Ketamine (50 mg/ml, Panpharma, Fougères, France) and Xylazine (2%, Rompun, Bayer, Leverkusen, Germany) (2:1 vol/vol) and was maintained throughout the experiment by injecting half a dose hourly. A heating pad maintained the body temperature between 36.5 and 37.5°C. The animals breathed spontaneously. The animal's head was fixed in ventral position with a head holder.
The endolymphatic sac was approached through the posterior cerebral fossa under stereomicroscopic observation (Carl Zeiss, Oberkochen, Germany). After suboccipital craniotomy, the dura mater of the posterior fossa was opened, and the endolymphatic sac was approached intradurally following retraction of the hemicerebellum.
pH lum Measurement
pH lum was measured with a double-barrelled glass microelectrode (one barrel for the ESP recording; the other for proton electrochemical recording) with an outside tip diameter of ϳ1 m. The technique for the construction of these microelectrodes has been described in detail elsewhere (18, 29) . One channel was exposed to silane vapours (dimethyltrimethyl-silylamine, Fluka, Sigma) before introducing a droplet of H ϩ ion exchanger. Preliminary tests on drug interference with pH sensitivity led us to use the 95297 exchanger, except for ethylisopropylamiloride (EIPA) experimental series for which 95293 exchanger was used (Fluka, Sigma). On the day of the experiment, the conventional barrel of the microelectrode was backfilled with 150 mM NaCl, and the selective channel was backfilled with a solution containing (in mM) 500 KCl, 64.7 KH 2 PO 4 , and 85.3 Na 2 HPO 4 . The microelectrode tip was immersed for at least 1 h in a Trizma base solution buffered to pH 7.0 with HCl.
The microelectrode was connected via Ag/AgCl electrodes to the input of a high-impedance electrometer (WPI FD 223, World Precision Instruments, Sarasota, FL) whose output was displayed with a pen chart recorder (SRM, Sefram, Paris, France). The electrical circuit was closed by a macroelectrode containing 150 mM NaCl in agarose. pH selectivity was tested in Trizma base/HCl solutions adjusted to various pH values in the range of 6.4-7.4. The slope, S, of the electrodes ranged from 50 to 61 mV per pH unit change. For the experiment, the reference macroelectrode was inserted into the neck muscles, and the tip of the microelectrode was submerged in a superfusing fluid [(in mM) 140 NaCl, 5 KCl, 1 CaCl 2 , 1 MgCl 2 , 5 TES, pH 7.4, osmolarity ϭ 280 mosM] delivered at a rate of 5 ml/min over the endolymphatic sac area. Zero potential and reference pH (pH ref ) were determined by submerging the microelectrode in the superfusing fluid. The pH lum was calculated according to the equation pH lum ϭ pH ref Ϫ (V H Ϫ ESP)/S, where the proton electrochemical recording (V H ) and the ESP were measured by advancing, by means of a micromanipulator (MM3, Narishige, Tokyo, Japan) and under stereomicroscopic observation, the microelectrode into the lumen of the sac and were recorded directly on the chart recorder. At the end of the experiment, the microelectrode was replaced in the reference solution. Results obtained with drifting microelectrodes were rejected.
Local Injections of Various Drugs
The time course of pH lum under different conditions was studied in 84 animals. The initial pH lum was measured before injecting 5 l of either the control or an experimental solution. The solution was slowly injected (taking 5 to 10 min) through a glass micropipette (tip diameter ϳ5-6 m) introduced, after penetration of the dura mater, into the area of the extraosseous portion of the endolymphatic sac. The pH lum was then measured continuously up to 90 min after the end of the injection.
The effect of the control solution [(in mM) 140 NaCl, 5 KCl, 1 CaCl 2 , 1 MgCl 2 , 5 TES, pH 7.4] on pH lum was tested in 17 animals. Nine other separate experimental series were performed in which the injected solutions contained the following: acetazolamide (10 Ϫ3 M, n ϭ 10; Diamox, Theraplix, Paris, France), ouabain (10 Ϫ3 M, n ϭ 9; Sigma, St. Louis, MO), bafilomycin A 1 (10 Ϫ5 M, n ϭ 8; gift of K. Altendorf, Osnabrü ck, Germany), Schering 28080 (Sch 28080) (10 Ϫ6 M, n ϭ 4; gift from Schering-Plough Research Institute, Kenilworth, NJ), amiloride (10 Ϫ4 M, n ϭ 12; Sigma), EIPA (10 Ϫ5 M, n ϭ 4; Interchim, Montluçon, France), DIDS (10 Ϫ3 M, n ϭ 6; Sigma), triflocin (10 Ϫ3 M, n ϭ 9; Lederle), and SITS (10 Ϫ3 M, n ϭ 3; Sigma). The drugs were dissolved directly in control solution, except for bafilomycin, which was dissolved in DMSO (final dilution 1/1,000 vol/vol). The pH of the injected solution was checked and eventually adjusted to pH 7.4.
Statistical Analysis
Data are expressed as mean Ϯ SE. Except when otherwise stated in the text, analysis of the results was performed by paired t-test for comparison with the initial pH lum value. Differences were considered significant at P Ͻ 0.05. The number of experiments corresponds to the number of injected endolymphatic sacs.
RESULTS
Initial Values of pH lum and ESP
Mean initial pH lum in the endolymphatic sac was 7.06 Ϯ 0.032 (n ϭ 84). Considerable variation was observed from one animal to another; values ranged from 6.35 to 7.60. No difference was observed between the different experimental series (Table 1 , one-way analysis of variance). The initial pH lum variable followed a normal distribution (median value 7.10). In blood, the initial pH value was 7.44 Ϯ 0.007 (n ϭ 47).
Mean initial ESP was ϩ6.1 Ϯ 0.34 mV (n ϭ 84), lumen positive, ranging from 1.0 to 18.8 mV. No difference was observed between the different groups of animals ( Table 2 , one-way analysis of variance). No statistical correlation was found between the initial pH lum and endolymphatic sac ESP values (y ϭ Ϫ0.09x ϩ 7.1, y in pH units, x in mV, r 2 ϭ 0.014, n ϭ 84).
Evolution of ESP After Drug Injection
When control saline solution was injected, the endolymphatic sac ESP decreased rapidly and had not completely recovered by 90 min (Table 2 ). This evolution did not fit with that observed in a previous study in which total recovery was observed at 60 min (8) . This could be due to technical differences such as the presence of TES buffer in the injected solution. Buffering of the injected solution was necessary to avoid an alteration of the basolateral pH, but TES may have interfered with ionic conductance(s) as previously reported (24) . In the presence of tested drugs, no significant difference in the evolution of the endolymphatic sac ESP was observed compared with the control injection, except for bafilomycin. Indeed, after injection of this drug, the ESP measured at 30 and 90 min was lower than that measured under control conditions (Student's t-test, P Ͻ 0.05, Table 2 ).
Evolution of pH lum After Drug Injection
Control experiments. When the control solution was injected, no pH change was observed in the luminal fluid up to 90 min after the injection (Table 1 , Fig. 1 ), whereas blood pH decreased slightly by 0.07 Ϯ 0.012 (final blood pH 7.37 Ϯ 0.012, n ϭ 47, P Ͻ 0.001, paired t-test). When both initial and final pH values were determined in blood and endolymphatic sac luminal fluid from the same animal, no correlation was found between the variations in blood pH and endolymphatic sac pH lum (y ϭ Ϫ0.14x ϩ 0.10, y ϭ blood pH, x ϭ sac pH lum , respectively, r 2 ϭ 0.148, n ϭ 10). Effect of carbonic anhydrase inhibitor on pH lum . When acetazolamide was injected, a rapid and sustained acidification of the pH lum was observed (Table 1, Fig. 2 ). This observation is best explained by the appearance of an acetazolamide-induced disequilibrium pH lum , supporting that net proton secretion takes place in the endolymphatic sac. Table 1 ). The lack of effect of these drugs suggests the absence of involvement of H ϩ -K ϩ -ATPase in luminal acid secretion (9) .
By contrast, bafilomycin A 1 , an inhibitor of the vacuolar type H ϩ -ATPase, had induced an increase in pH lum 30 min after its injection. Although this increase tended to subside, it was still significant 90 min after the injection (Fig. 3, Table 1 ).
Effect of Na/H antiporter inhibitors. Both EIPA, a Na/H exchange-specific inhibitor, and amiloride, used at a concentration known to inhibit Na/H exchange, failed to modify the pH lum ( Table 1) .
Effect of anionic transport systems inhibitors. Triflocin and SITS failed to alter the pH lum , whereas DIDS induced a rapid (significant as early as 5 min after the injection) and sustained pH decrease (Fig. 4) .
DISCUSSION
The purpose of the present in vivo study was to assess the acid-base homeostasis systems of the endolymphatic sac by testing the effects of locally applied drugs on the pH lum . Our results suggest a net apical proton secretion involving an apical, vacuolar type H ϩ -ATPase and an intracellular and/or apical membrane-bound carbonic anhydrase.
Endolymphatic Sac Local Drug Delivery
As already reported, experimental injection of solutions into the connective tissue surrounding the endolymphatic sac appears to be a likely route for inner ear gene transfer (33) . Regarding the inhibition of ionic transports, local injection allowed us to avoid the major drawbacks of systemic administration, especially the adverse side effects of the injected drugs and shifts in blood pH that could indirectly affect the pH lum of the endolymphatic sac. Considering the basolateral site of the injection, the long duration of the experiment, together with the absence of washing of the basolateral interstitial fluid, may have allowed luminal diffusion of the drug and thus precluded any precise localization of the inhibited transport system. Actually, some of the injected drugs, such as bafilomycin, probably acted on apical membrane transporters.
Net Acid Secretion in the Lumen of the Endolymphatic Sac
Positive ESP (ϩ6.1 mV) as well as acidic pH in the lumen (7.06) would drive a paracellular H ϩ absorption, which implies an equivalent transcellular H ϩ secretion in the steady state. Thermodynamic evidence of active proton extrusion from cell to lumen would require direct measurement of cell membrane potential and intracellular pH. However, the effect of bafilomycin on pH lum is an indirect but strong argument in favour of H ϩ active transport through the apical cell membrane, namely an H ϩ -ATPase. As bafilomycin caused an increase in pH, reaching 7.46, a pH that would correspond to a passive H ϩ transepithelial distribution, a vacuolar H ϩ -ATPase was probably responsible for at least most of the transepithelial H ϩ gradient in the endolymphatic sac. In view of the high concentrations of bafilomycin used in the present study, the specificity of this drug on vacuolar H ϩ -ATPase could be questioned. Nevertheless, in vitro studies showed that at 10 Ϫ5 M, bafilomycin A 1 is still highly specific of vacuolar H ϩ -ATPase (4). Moreover, once injected, bafilomycin was diluted in the basolateral compartment of the sac, so that its concentration at the site of its target transporter was probably Ͻ10 Ϫ5 M. Finally, our functional observations in favour of an apical vacuolar H ϩ -ATPase are consistent with immunohistochemical results (22) .
The absence of any effect of amiloride and EIPA on the pH lum of the endolymphatic sac is an additional argument for the predominant role of the H ϩ -ATPase in the maintenance of the pH lum . The presence of an apical Na ϩ /H ϩ antiporter has been postulated, in view of the decrease in the ESP after amiloride application (8) and the inhibition of acid-load recovery by amiloride on epithelial cells isolated from the endolymphatic sac (32) . Nevertheless, under the present experimental conditions, the maintenance of a stable pH lum after amiloride and EIPA injections suggests that the Na/H transport system may not be involved in the generation of the transepithelial acid gradient.
Acetazolamide, a drug known to inhibit carbonic anhydrase, caused a rapid and sustained decrease in the pH lum . This luminal acidification might have been the result of various effects of acetazolamide, including impairment of the acid-base transport systems. However, the most straightforward explanation is that acetazolamide induced an acid disequilibrium pH lum due to the inhibition of carbonic anhydrase in functional contact with the luminal fluid. A similar phenomenon takes place in the proximal tubule in the kidney, where acetazolamide or benzolamide induced an acid disequilibrium pH lum (19, 30) . Consistent with this hypothesis, an ultrastructural study showed that carbonic anhydrase was not only located in the cytoplasm, but it was also bound to apical and basolateral membranes of the mitochondria-rich cells of the endolymphatic sac (25) .
Net Reabsorption of HCO 3 Ϫ or Equivalent Species from Lumen to Endolymphatic Sac
Net proton secretion into the lumen of the sac is expected to be coupled to a transepithelial reabsorption of HCO 3 Ϫ or equivalent species. Yet the present study failed to detect any effect of various inhibitors of HCO 3 Ϫ transport systems. Inhibitors of Cl Ϫ /HCO 3 Ϫ exchanger and more generally of anionic transport systems, including Na ϩ -HCO 3 Ϫ cotransport, such as SITS, triflocin, and DIDS (2, 7), did not cause alkalinization of the luminal fluid. On the contrary, DIDS induced a decrease in the pH lum . At the concentration used in the present study, DIDS has been reported to inhibit Cl channels (15) and paradoxically to activate ion transport systems such as nonselective cationic channels (10) or I sK K channels (6) . Thus although DIDS-induced luminal acidification may result from the inhibition of an apical base-equivalent transport mechanism on the apical membrane, such as a Cl Ϫ /HCO 3 Ϫ exchanger, no firm conclusion can be drawn from the present observations. Further studies with molecular tools are necessary to elucidate the site of action of DIDS.
Correlation Between ESP
In the present study, no correlation was found in basal conditions (before drug administration) between endolymphatic sac ESP and pH lum . Moreover, in the control group, evolution of ESP was biphasic, with an initial decrease followed by partial recovery, whereas pH lum remained stable throughout the experiment. Thus although the decrease in the ESP by bafilomycin suggested the participation of this ATPase in the genesis of the ESP, other transport systems, such as Na and K conductances and/or Na-K-2Cl cotransport, probably play a major role in this process (17, 28, 31) .
Role of Luminal Net Acid Secretion in Endolymph Homeostasis and Clinical Involvements
The acidity of the luminal fluid in the endolymphatic sac relative to blood physiological pH probably contributes to endolymph homeostasis in different ways. First, it might modify the activity of aquaporins involved in endolymph resorption. Indeed, the osmotic water permeability of AQP3, an aquaporin whose mRNA has been detected by RT-PCR in rat endolymphatic sac (1) , is inhibited by low extracellular pH (34) . Second, low pH lum might activate the degradation of luminal precipitates of osmotically active luminal glycoconjugates by free-floating macrophages (3, 12) .
Mutations of the B1 subunit of the vacuolar H ϩ -ATPase have recently been shown to lead to sensorineural hearing impairment associated with distal tubular acidosis (13) . The B1 subunit has been localized in the endolymphatic sac by immunohistochemistry (13) . The specific involvement of vacuolar H ϩ -ATPase of the endolymphatic sac in this genetic deafness remains to be determined.
Perspectives
Our results are consistent with active luminal proton secretion by means of an apical bafilomycin A 1 -sensitive vacuolar H ϩ -ATPase and with the presence of intracellular and membrane-bound carbonic anhydrases.
The resulting luminal acidity relative to blood pH probably participates in the homeostasis of endolymph by interacting with aquaporins and/or with the degradation of luminal glycoconjugates by macrophages. This regulation is a tempting explanation for the contrary effects of acetazolamide in endolymph homeostasis, depending on whether the endolymphatic sac is functional (21, 26) . Indeed, after destruction of the sac, this diuretic prevented the development of endolymphatic hydrops (21) , whereas it induced mild endolymphatic hydrops when the endolymphatic sac was intact (26) . On a more general standpoint, one must take into account the acid-base transport systems of the endolymphatic sac when predicting or interpreting the efficacy on Ménière's disease of diuretics that interact with the acid-base balance. The role of the endolymphatic sac apical H ϩ -ATPase in the pathophysiology of genetic deafness resulting from mutations of the B1 subunit of this pump remains to be determined.
